Executive Summary
Decentralized clinical trials are changing how pharmaceutical companies think about the economics of clinical research.
Traditional trials often require...
Executive Summary
Artificial intelligence (AI) is becoming a strategic investment priority for pharmaceutical companies seeking to improve productivity, accelerate drug...
Executive Summary
Clinical trials are moving beyond the traditional model in which participants repeatedly visit research sites for assessments, monitoring,...
Executive Summary
Drug discovery is becoming increasingly dependent on understanding the biological systems that drive disease. Genomics has helped researchers...
Executive Summary
Precision medicine is moving from a largely genomics-driven model toward a broader approach that combines molecular, clinical, imaging,...
Executive Summary
Clinical research is expanding beyond measurements collected during scheduled site visits. Wearables, smartphones, connected medical devices, and digital...